In prognostic value analysis, we discovered that high MTHFD2 expression was a risky factor for patients’ survival in many cancer types, which is in line with previous studies and the theory that high MTHFD2 expression can help cancer cells meet the high biosynthetic requirement (19–24). The gene discussed is MTHFD2; the disease is cancer.